This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Edi (Experimentelle & Diagnostische Immunologie) Gmbh, Edi Gmbh, Hot Screen Gmbh. Active years: 2002-2015.
Company Filing History:
1 out of 1 
1 out of 2 
1 out of 1 Years Active: 2002-2015
Title: Manfred Schmolz: Innovator in Cell Culture Systems
Introduction
Manfred Schmolz is a notable inventor based in Reutlingen, Germany. He has made significant contributions to the field of cell culture systems, focusing on the sensitizing, allergenic, and irritating effects of substances. With a total of 3 patents, Schmolz's work has implications for both diagnostics and therapeutic tracking in medical science.
Latest Patents
One of Schmolz's latest patents is a cell culture system designed for determining the sensitizing, allergenic, and/or irritating effects of substances. This innovative system comprises a first compartment containing an epidermis model and a second compartment with a cell culture based on immune cells, allowing for effective communication between the two via a permeable interlayer. Another significant patent involves ILCS-based pattern recognition of sepsis. This method focuses on recognizing and characterizing cellular activity patterns for diagnostic purposes, particularly in tracking the therapy of diseases. Blood cells are stimulated in a culture medium with toll-like receptor ligands, and the stimulated blood cells and/or the culture medium are examined for analysis.
Career Highlights
Throughout his career, Schmolz has worked with esteemed institutions such as the University of Ulm and Edi GmbH. His experience in these organizations has contributed to his expertise in the field of cell culture and immunology.
Collaborations
Some of Schmolz's notable coworkers include Marion E Schneider and Rolf Kaufmann. Their collaborative efforts have likely enhanced the research and development of innovative solutions in their respective fields.
Conclusion
Manfred Schmolz's contributions to cell culture systems and his innovative patents reflect his dedication to advancing medical science. His work continues to influence the understanding of cellular responses and therapeutic approaches.